MDRX

Veradigm Inc. Common Stock

Delisted

MDRX was delisted on the 28th of February, 2024.

 

About: Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Employees: 7,869

Financial journalist opinion

Neutral
Business Wire
1 month ago
Veradigm Provides 2025 Financial & Business Update
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, is providing an update on commercial activity and estimated financial performance for the first quarter of 2025 compared to the prior year, details about its recent financing, and reaffirmation of its outlook for the 2025 fiscal year. “The year started on a positive note by closing deals with over $30 million in annual contract value in the first quarter of 2025, a 25 percent inc.
Veradigm Provides 2025 Financial & Business Update
Neutral
Business Wire
1 month ago
Veradigm to Release Business Update June 23rd and Host Investor Call June 24th
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that management plans to provide a business update after the close of regular stock market hours on June 23, 2025. Veradigm management plans to host an investor conference call and webcast the Company's update at 8:00 a.m. Eastern Time on June 24, 2025. Update Call Details Veradigm plans to distribute an announcement promptly after the close of regular stock marke.
Veradigm to Release Business Update June 23rd and Host Investor Call June 24th
Neutral
Business Wire
1 month ago
Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, today launched the Smart Medicine Podcast, hosted by renowned podcaster and orthopedic surgeon, Dr. Scott Sigman. The show will provide insights and inspiration for clinicians along with other healthcare professionals, as well as payer and life science industry leaders striving to navigate the complexities of modern medicine through incremental insight. The podcast features exper.
Veradigm Launches Smart Medicine Podcast to Explore the Evolution of Healthcare
Neutral
Business Wire
2 months ago
Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, along with Metroplex Medical Centres and one of the largest healthcare payer organizations in the country, received a 2025 KLAS Points of Light Award. The case study titled, “Optimizing Value-Based Care by Delivering Insights at the Point of Care,” showcased how Veradigm and the payer integrated alerts into Metroplex Medical Centres' electronic health record (EHR) to help improve.
Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care
Neutral
Business Wire
2 months ago
Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation
CHICAGO--(BUSINESS WIRE)-- #CardiometabolicResearch--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today an advancement in the use of artificial intelligence (AI) to scale the generation of real-world evidence (RWE) for GLP-1 receptor agonists (GLP-1 RAs), including semaglutide and tirzepatide. By applying AI to electronic health record (EHR) deidentified data within the Veradigm Network, researchers can now surface rich, contextual insights—such as side effects, dis.
Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation
Neutral
Business Wire
3 months ago
Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payer Analytics the overall number one provider of payer analytics solutions for health plans. Veradigm has achieved this ranking for the second year in a row, also earning top marks in 2024. Veradigm Payer Analytics earned top category.
Black Book Ranks Veradigm Payer Analytics the #1 Overall Payer Analytics Solution Vendor in 2025
Neutral
Business Wire
3 months ago
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Syracuse Orthopedic Specialists has selected elements from the Veradigm solution suite, Veradigm Revenue Cycle Services and Coding Services designed to support growth, improve cash flow and reduce costs. Syracuse Orthopedic Specialists, located near Syracuse, NY, provides total orthopedic care to the surrounding regions, and is currently utilizing Veradigm Re.
Syracuse Orthopedic Specialists Selects Veradigm to Achieve Exceptional Financial Health and Operational Efficiency
Neutral
Seeking Alpha
4 months ago
Veradigm Inc. (MDRX) Investor Update Call Transcript
Veradigm Inc. (OTC:MDRX) Investor Update Call March 19, 2025 8:00 AM ET Company Participants Jenny Gelinas - VP, IR Tom Langan - Interim CEO Lee Westerfield - Interim CFO Conference Call Participants Charles Rhyee - TD Cowen Jeff Garro - Stephens George Hill - Deutsche Bank Operator Greetings, and welcome to the Veradigm Investor Update Call. At this time, all participants are in a listen-only mode.
Veradigm Inc. (MDRX) Investor Update Call Transcript
Neutral
Business Wire
4 months ago
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
CHICAGO--(BUSINESS WIRE)--Veradigm Inc. (OTCMKTS: MDRX) (“Veradigm” or the “Company”), a leading provider of healthcare data and technology solutions, announced today its Board of Directors (the “Board”) appointed two new independent directors, Jonathan Sacks and Bruce Felt, to the Board, effective March 19, 2025, and that Lou Silverman will succeed Greg Garrison as Chairman upon his retirement from the Board on that date. In addition, Mr. Felt will become the Chair of the Audit Committee of th.
Veradigm Announces Appointment of Two New Independent Directors and Transition of Board Leadership
Neutral
Business Wire
4 months ago
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
CHICAGO--(BUSINESS WIRE)--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, provided updates on financial information for fiscal 2023 and 2024 and an outlook for fiscal 2025. “We remain confident in Veradigm's business model and our value proposition,” said Tom Langan, Interim Chief Executive Officer. “We believe our core business is sound. We remain focused on remediating our material weaknesses and other internal control deficiencies, becoming current.
Veradigm Provides Updates on Fiscal 2023 and 2024 and an Outlook for Fiscal 2025
Charts implemented using Lightweight Charts™